Cite
Safety and immunogenicity of the bi-cistronic GLS-5310 COVID-19 DNA vaccine delivered with the GeneDerm suction device.
MLA
Kim, Woo Joo, et al. “Safety and Immunogenicity of the Bi-Cistronic GLS-5310 COVID-19 DNA Vaccine Delivered with the GeneDerm Suction Device.” International Journal of Infectious Diseases, vol. 128, Mar. 2023, pp. 112–20. EBSCOhost, https://doi.org/10.1016/j.ijid.2022.12.037.
APA
Kim, W. J., Roberts, C. C., Song, J. Y., Yoon, J. G., Seong, H., Hyun, H.-J., Lee, H., Gil, A., Oh, Y., Park, J., Jeon, B., Lee, J.-E., Choi, S. K., Yoon, S. K., Lee, S., Kim, B., Kane, D., Spruill, S., Kudchodkar, S. B., & Muthumani, K. (2023). Safety and immunogenicity of the bi-cistronic GLS-5310 COVID-19 DNA vaccine delivered with the GeneDerm suction device. International Journal of Infectious Diseases, 128, 112–120. https://doi.org/10.1016/j.ijid.2022.12.037
Chicago
Kim, Woo Joo, Christine C. Roberts, Joon Young Song, Jin Gu Yoon, Hye Seong, Hak-Jun Hyun, Hyojin Lee, et al. 2023. “Safety and Immunogenicity of the Bi-Cistronic GLS-5310 COVID-19 DNA Vaccine Delivered with the GeneDerm Suction Device.” International Journal of Infectious Diseases 128 (March): 112–20. doi:10.1016/j.ijid.2022.12.037.